Search Login Register

Necrobiotic Xanthogranuloma Summary

Description: A cutaneous necrobiotic disorder characterized by firm, yellow plaques or nodules, often in a periorbital distribution. It is often accompanied by an elevated ERYTHROCYTE SEDIMENTATION RATE; LEUKOPENIA; and MONOCLONAL GAMMOPATHY (IgG-kappa type) and systemic involvement.

Also Known As: Necrobiotic Xanthogranulomas; Xanthogranuloma, Necrobiotic; Xanthogranulomas, Necrobiotic

Networked: 63 relevant articles (3 outcomes, 2 trials/studies) for this Disease

Key Drugs and Agents for Necrobiotic Xanthogranuloma

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Prednisolone (Predate) : 1 outcome in 4 results : FDA 55 Generic
  2. Melphalan (Alkeran) : 1 outcome in 4 results : FDA 2 Generic
  3. Interferons : 1 outcome in 2 results : IBA
  4. Ficusin (Psoralen) : 1 outcome in 1 result : IBA
  5. Immunoglobulin G (IgG) : 1 study in 12 results : IBA
  6. Immunoglobulins (Immunoglobulin) : 1 study in 5 results : IBA
  7. Dexamethasone (Maxidex) : 5 results : FDA 77 Generic
  8. Immunoglobulin A (IgA) : 4 results : IBA
  9. Cholesterol : 4 results : IBA
  10. Chlorambucil (Leukeran) : 4 results : FDA 1
Show All >>

Diseases Related to Necrobiotic Xanthogranuloma

  1. Neurologic Manifestations (Neurological Manifestations)
  2. Paraproteinemias (Monoclonal Gammopathy)
  3. Necrobiosis Lipoidica
  4. Multiple Myeloma
  5. Granuloma
Show All >>

Key Therapies for Necrobiotic Xanthogranuloma

Efficacy Chart >>
  1. Plasmapheresis : 1 outcome in 2 results
  2. Drug Therapy (Chemotherapy) : 1 outcome in 1 result
  3. Stem Cell Transplantation : 1 result
  4. Blepharoplasty : 1 result
  5. Transplants (Transplant) : 1 result
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.